Kapp M - Search Results

1

Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases.

Rasche L, Bernard C, Topp MS, Kapp M, Duell J, Wesemeier C, Haralambieva E, Maeder U, Einsele H, Knop S. Rasche L, et al. Among authors: kapp m. Ann Hematol. 2012 Jul;91(7):1031-7. doi: 10.1007/s00277-012-1414-5. Ann Hematol. 2012. PMID: 22286070

2

Challenges to preventing infectious complications, decreasing re-hospitalizations, and reducing cost burden in long-term survivors after allogeneic hematopoietic stem cell transplantation.

Fuji S, Kapp M, Einsele H. Fuji S, et al. Among authors: kapp m. Semin Hematol. 2012 Jan;49(1):10-4. doi: 10.1053/j.seminhematol.2011.10.009. Semin Hematol. 2012. PMID: 22221780 Review.

3

EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT.

Rasche L, Kapp M, Einsele H, Mielke S. Rasche L, et al. Among authors: kapp m. Bone Marrow Transplant. 2014 Feb;49(2):163-7. doi: 10.1038/bmt.2013.96. Epub 2013 Jul 8. Bone Marrow Transplant. 2014. PMID: 23832092 Review.

4

Cellular therapy to control tumor progression.

Kapp M, Rasche L, Einsele H, Grigoleit GU. Kapp M, et al. Curr Opin Hematol. 2009 Nov;16(6):437-43. doi: 10.1097/MOH.0b013e32832f57d4. Curr Opin Hematol. 2009. PMID: 19587587 Review.

5

Immunotherapy for viral and fungal infections.

Einsele H, Löffler J, Kapp M, Rasche L, Mielke S, Grigoleit UG. Einsele H, et al. Among authors: kapp m. Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S51-4. doi: 10.1038/bmt.2015.96. Bone Marrow Transplant. 2015. PMID: 26039208 Review.

6

Cytomegalovirus disease in hematopoietic stem cell transplant patients: current and future therapeutic options.

Fuji S, Einsele H, Kapp M. Fuji S, et al. Among authors: kapp m. Curr Opin Infect Dis. 2017 Aug;30(4):372-376. doi: 10.1097/QCO.0000000000000375. Curr Opin Infect Dis. 2017. PMID: 28505028 Review.

7

Monitoring of pathogen-specific T-cell immune reconstitution after allogeneic hematopoietic stem cell transplantation.

Fuji S, Kapp M, Einsele H. Fuji S, et al. Among authors: kapp m. Front Immunol. 2013 Sep 17;4:276. doi: 10.3389/fimmu.2013.00276. Front Immunol. 2013. PMID: 24062744 Free PMC article. Review.

8

Alloreactivity of virus-specific T cells: possible implication of graft-versus-host disease and graft-versus-leukemia effects.

Fuji S, Kapp M, Einsele H. Fuji S, et al. Among authors: kapp m. Front Immunol. 2013 Oct 14;4:330. doi: 10.3389/fimmu.2013.00330. Front Immunol. 2013. PMID: 24133497 Free PMC article. Review.

9

Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Fuji S, Kapp M, Einsele H. Fuji S, et al. Among authors: kapp m. Front Oncol. 2014 Apr 24;4:89. doi: 10.3389/fonc.2014.00089. eCollection 2014. Front Oncol. 2014. PMID: 24795865 Free PMC article. Review.

10

Control of relapsed or refractory acute myeloid leukemia by clofarabine in preparation for allogeneic stem cell transplant.

Loeffler C, Kapp M, Grigoleit GU, Mielke S, Loeffler J, Heuschmann PU, Malzahn U, Hupp E, Einsele H, Stuhler G. Loeffler C, et al. Among authors: kapp m. Leuk Lymphoma. 2015;56(12):3365-9. doi: 10.3109/10428194.2015.1020059. Epub 2015 Sep 24. Leuk Lymphoma. 2015. PMID: 26014275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters